Trialect

Not Verified

Expired

MRFF 2024 National Critical Research Infrastructure Grant Opportunity

National Health and Medical Research Council

The 2024 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams.

Stream 1 – Innovation enablers

Addresses an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel research platforms, and secure health data environments to create valuable research resources.

Stream 2 – Digitisation of health care

Developing and translating into practice digital therapeutics, artificial intelligence enabled health interventions and technologies (e.g. wearables integrated into clinical practice), applications or other software for use in clinical practice.

Stream 3 – Co-investment partnerships

Utilising co-investment (cash only) with the research sector, state and/or territory governments, and industry, in significant critical research infrastructure (e.g. facilities, personnel and equipment):

to support development of research capacity, capability and/or effectiveness in an area of unmet medical need, or
to enable Australian research using new platforms, systems and services in an area of unmet medical need.

Stream 4 – mRNA technology enablers

Leveraging and enhancing emerging mRNA technologies, platforms, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need.

An application may only be submitted to one of the above four streams only. Applicants must specify the stream to which they are applying in their application.

Specialties

Drug Delivery

Genetics & Genomics

Public Health

Technology Development

Drug Development

Healthcare Delivery

Rare Diseases

Eligibility Requirements

Eligibility:

You can apply if you:

have an Australian business number (ABN)
are incorporated in Australia

and in accordance with s24 of the Medical Research Future Fund Act 2015, are one of the following entities:

a medical research institute
a university
a corporate Commonwealth entity
a corporation (including businesses and not for profits).

You can’t apply if you are:

an organisation, or your project partner is an organisation, included on the National Redress Scheme’s list of Institutions that have not joined or signified their intent to join the Scheme
an employer of 100 or more employees that has not complied with the Workplace Gender Equality Act (2012)
an individual
a partnership
an unincorporated association
a trust (however, an incorporated trustee may apply on behalf of a trust)
a non-corporate Commonwealth entity
any organisation not listed in the eligible entity list.

Partner with other organisations

Joint applications are encouraged.

You can partner with one or more other organisations but you must decide who the lead organisation is.

Stream 3 applications must be from a consortia (including the applicant):

of at least one academic organisation and at least one other organisation which may be industry or state/territory government
with combined cash contributions of at least 34% of the total eligible project costs.

The lead organisation must fill out the application form and enter into the grant agreement with the Commonwealth.

If we give your group the grant, the lead organisation:

signs the grant agreement
receives grant payments
is responsible for making sure your group follows all requirements in the grant agreement, including all reporting requirements.

Eligible Countries:

Australia

Sponsor Details

Sponsor Institute/Organizations: National Health and Medical Research Council

Sponsor Type:

Address: National Health and Medical Research Council (NHMRC), Level 1, 16 Marcus Clarke Street, Canberra, ACT 2601

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.